Phio Pharmaceuticals Corp. (PHIO)
1.22
+0.04
(+3.39%)
USD |
NASDAQ |
Mar 20, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Phio Pharmaceuticals Research and Development Expense (Quarterly) : 1.477M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 16.94M |
| Jaguar Health, Inc. | 3.658M |
| MetaVia, Inc. | 1.914M |
| Seastar Medical Holding Corp. | 1.85M |
| Jupiter Neurosciences, Inc. | 0.8167M |